• Home
  • News
  • Market Data
  • Participants
  • Issuers
  • Investors
  • Education
  • Profile

Cookie notification

Our website uses cookies. This enables us to optimize your user experience. By continuing to use our website, you agree to this. To find out more, please see our Privacy Policy.


Special Life Sciences Indices enhance visibility

The two sector indices - SXI LIFE SCIENCES® and SXI Bio+Medtech® give the industry greater visibility in the financial market and have a positive impact on liquidity.

The SXI LIFE SCIENCES® index comprises companies from the pharmaceutical, biotechnology and medical technology areas, while its sub-index - the SXI Bio+Medtech® - focuses solely on bio- and medtech companies. Both indices open to Swiss and foreign companies alike and since their initial calculation in December 1999 have turned in impressive performances in an international comparison. The maximum weighting of any given stock is limited to 10%, which gives greater prominence to small- and medium-sized companies. Index inclusion is possible from day one, raising your company’s profile right after listing.

SXI LIFE SCIENCES® index performance comparison

Source: FactSet, January 2020